Skip to content
Skip to navigation menu

News archive for School of Medicine Research

  • Dementias Platform UK: A powerhouse for dementia research 27th October 2014A ground-breaking, multimillion pound collaboration between industry and academia, set up by the Medical Research Council, will hold its inaugural conference on 28th October 2014.
  • NISCHR health fellowship awarded to Dr John Ingram 24th October 2014Dr Ingram was recently awarded a 5-year fellowship by the National Institute for Social Care and Health Research (NISCHR) to investigate hidradenitis suppurativa.
  • Diagnostic tool for leading viral cause of birth defects 15th October 2014Researchers from Cardiff and Swansea Universities have been awarded a grant of more than £323k to develop a new, non-invasive, low-cost, and easy to use point of care device to diagnose Human Cytomegalovirus (HCMV).
  • Counting the seconds for immunological tolerance 3rd October 2014Researchers from Basel (Switzerland), in collaboration with Prof Andrew Sewell and Dr David Cole from Cardiff University and colleagues from Cambridge (USA), discover that the immune system uses a molecular biological clock to target intolerant T cells during their maturation …
  • CMV research on BBC Wales Today www.facebook.com30th September 2014I&I scientists Richard Stanton and Ian Humphreys discuss their latest discoveries on BBC Wales Today.
  • Using a virus to understand how the immune system works 16th August 2014Cardiff researchers have used a human herpesvirus to uncover fundamental insights into how immune cells kill virus infected cells. The work was published in the leading journal ‘Cell host & Microbe’.
  • Improvement Collaboratives in Healthcare 24th July 2014This evidence scan explores research about whether collaboratives help to improve quality in health care and the factors that may be key to their success.
  • New test predicts survival in blood cancer patients Cardiff University9th July 2014Scientists have developed a test which accurately predicts the prognosis for patients with the most common form of leukaemia. The findings could also inform the development of a prognostic test for patients with other forms of cancer.